COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,301 Articles (22,772 medRxiv, 8,529 bioRxiv)

Most recent first Previous |  Page 2428: Articles 24271-24280  | Next

Magnitude, demographics and dynamics of the impact of the first phase of the Covid-19 pandemic on all-cause mortality in 17 industrialised countries
Kontis, V., Bennett, J. E., Rashid, T., Parks, R. M., Pearson-Stuttard, J., Guillot, M., Asaria, P., Zhou, B., Battaglini, M., Corsetti, G., McKee, M., Di Cesare, M., Mathers, C. D., Ezzati, M.
10.1101/2020.07.26.20161570 — Posted: 2020-07-28 Discussion: Onsite
Modeling Control, Lockdown & Exit Strategies for COVID-19 Pandemic in India
Barman, M., Nayak, S., Yadav, M. K., Raha, S., Mishra, N.
10.1101/2020.07.25.20161992 — Posted: 2020-07-28
AutoSEIR: Accurate Forecasting from Real-time Epidemic Data Using Machine Learning
Rizzo, S. G., Vantini, G., Saad, M., Chawla, S.
10.1101/2020.07.25.20159715 — Posted: 2020-07-28
Levels of the TNF related cytokine, LIGHT increase in hospitalized COVID-19 patients with Cytokine Release Syndrome and ARDS
Perlin, D. S., Zafir-Lavie, I., Roadcap, L., Raines, S., Ware, C. F., Neil, G. A.
10.1101/2020.07.27.20152892 — Posted: 2020-07-28
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
Pawlowski, C., Puranik, A., Bandi, H., Venkatakrishnan, A., Agarwal, V., Kennedy, R., O'Horo, J. C., Gores, G. J., Williams, A. W., Halamka, J., Badley, A. D., Soundararajan, V.
10.1101/2020.07.27.20161976 — Posted: 2020-07-28 Discussion: Onsite | Offsite
Effectiveness and Safety of Chloroquine or Hydroxychloroquine as a mono-therapy or in combination with Azithromycin in the treatment of COVID-19 patients: Systematic Review and Meta-Analysis
Ghazy, R. M., Almaghraby, A., Shaaban, R., Kamal, A., Beshir, H., Moursi, A., Taha, S. H. N., Ramadan, A.
10.1101/2020.07.25.20162073 — Posted: 2020-07-28
30-day mortality and morbidity in COVID-19 versus influenza: A populationbased study
Nersesjan, V., Amiri, M., Christensen, H. K., Benros, M. E., Kondziella, D.
10.1101/2020.07.25.20162156 — Posted: 2020-07-28
SARS-CoV-2 viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis
Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E., Schafers, J., Ho, A.
10.1101/2020.07.25.20162107 — Posted: 2020-07-28 Discussion: Onsite
Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs
Akgun Dogan, O., Kose, B., Agaoglu, N. B., Yildiz, J., Alkurt, G., Kendir Demirkol, Y., Irvem, A., Dinler-Doganay, G., Doganay, L.
10.1101/2020.07.26.20158618 — Posted: 2020-07-28
A Bayesian Framework for Estimating the Risk Ratio of Hospitalization for People with Comorbidity Infected by the SARS-CoV-2 Virus
Gao, X., Dong, Q.
10.1101/2020.07.25.20162131 — Posted: 2020-07-28 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).